Breaking News Bar

Business News and Information

AstraZeneca sells the rights to two hypertension drugs in $400M deal

AstraZeneca will get $250 million when the deal closes and another $150 million by the middle of next year.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear